The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy by consolidation administration site: Subgroup analysis of a phase III study of CPX-351 versus 7+3 in older adults with newly diagnosed, high-risk acute myeloid leukemia (AML).
 
Jonathan E. Kolitz
Stock and Other Ownership Interests - Celgene
Honoraria - Gilead Sciences; Magellan Health; Novartis
Consulting or Advisory Role - Gilead Sciences; Magellan Health; Novartis; Pharmacyclics; Seagen
Research Funding - Boehringer Ingelheim; Cantex Pharmaceuticals; ERYTECH Pharma; Millennium
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Seagen
 
Stephen Anthony Strickland
Honoraria - Astellas Pharma
Consulting or Advisory Role - Alexion Pharmaceuticals; Baxalta; Boehringer Ingelheim; CTI; Daiichi Sankyo; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Research Funding - Boehringer Ingelheim; Sunesis Pharmaceuticals
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)
 
Donna Hogge
No Relationships to Disclose
 
Jeffrey E. Lancet
Consulting or Advisory Role - Asterias Biotherapeutics; Baxalta; Bio-Path Holdings, Inc; Biosight; Boehringer Ingelheim; Celator; Celgene; ERYTECH Pharma; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Novartis
Research Funding - Pfizer (Inst)
 
Stuart L. Goldberg
Employment - COTA
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Celgene; Novartis
Research Funding - Ambit BioSciences (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Novartis
 
Karen C Chung
Employment - Gilead Sciences; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Amgen; Baxalta; Baxter; Bayer; Gilead Sciences; Jazz Pharmaceuticals; Shire
Travel, Accommodations, Expenses - Gilead Sciences; Jazz Pharmaceuticals
 
Robert Ryan
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Michael Chiarella
Employment - Celator; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
 
Arthur Chin Louie
Employment - Jazz Pharmaceuticals
Leadership - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Celator
 
Robert K. Stuart
Honoraria - Sunesis Pharmaceuticals
Consulting or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Agios; Astellas Pharma; Bayer; Celator; Incyte; Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Sunesis Pharmaceuticals
 
Bruno C. Medeiros
Honoraria - Amgen; Astellas Pharma; Jazz Pharmaceuticals
Consulting or Advisory Role - Amgen; Astellas Pharma; Celator; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech
Research Funding - Astellas Pharma; Celator; Celgene; MEI Pharma; Merck/Schering Plough; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Celator; Celgene; Jazz Pharmaceuticals; Novartis